← Back to FLGT

Fulgent Genetics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 30/07/2026Mar 2026Filed 01/05/2026Sep 2025Filed 07/11/2025Jun 2025Filed 30/07/2026Mar 2025Filed 01/05/2026Sep 2024Filed 07/11/2025Jun 2024Filed 01/08/2025Mar 2024Filed 02/05/2025
$85$71$84$82$73$72$71$64
−$30−$25−$6.6−$19−$12−$15−$8.7−$13
2831313131303030

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.